Form 4: Stepan VP & CHRO Granted Equity Awards
Insider Transaction Disclosure
Stepan Company's VP & CHRO, Andrea Jean Barry, received grants of Restricted Stock Units, Stock Appreciation Rights, and Performance Shares on November 7, 2025.
Summary
- Andrea Jean Barry, VP & CHRO of Stepan Company, was granted equity awards on November 7, 2025.
- Awards include 1,159 Restricted Stock Units (RSUs), each representing a contingent right to one share of common stock.
- The RSUs will vest ratably over three years starting November 7, 2026, with an expiration date of November 7, 2028.
- Also granted were 1,638 Stock Appreciation Rights (SARs) with an exercise price of $43.15.
- The SARs will vest ratably over three years starting November 7, 2026, and expire on November 7, 2035.
- Additionally, 579 Performance Shares were granted, contingent on Stepan Company achieving specific performance goals for the period ending December 31, 2027.
- All awards were granted at a price of $0.
Sentiment
Score: 7
Explanation: The grant of equity awards to a key executive is generally a positive signal, aligning management incentives with shareholder interests. It reflects ongoing compensation and retention strategies.
Positives
- Grant of equity awards aligns management's interests with shareholder value creation.
- The awards include performance-based shares, incentivizing the achievement of company goals.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of executive equity compensation and does not provide broader industry context or trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Andrea J. Barry granted a Power of Attorney to Shawn G. Lisle, Kamel Aranki, and James A. Hart to execute Forms 3, 4, and 5 on her behalf. | 2025-09-30 | Streamlines the process for filing Section 16 reports for the reporting person, ensuring timely compliance with SEC regulations. |
Stakeholder Impact
- Shareholders: Executive equity grants align management's long-term interests with shareholder value creation, potentially leading to improved company performance.
- Employees: Reflects standard executive compensation practices, which can influence overall compensation philosophy within the company.
Next Steps
- Vesting of Restricted Stock Units and Stock Appreciation Rights will commence ratably over three years starting November 7, 2026.
- Performance Shares will vest upon certification of Stepan Company achieving certain performance goals for the period ending December 31, 2027.
Key Dates
| Date | Description |
|---|---|
| 2025-09-30 | Power of Attorney executed by Andrea J. Barry. |
| 2025-11-07 | Date of transaction for equity awards granted to Andrea J. Barry. |
| 2025-11-10 | Date the Form 4 was signed by the attorney-in-fact. |
| 2026-11-07 | Start date for ratable vesting of Restricted Stock Units and Stock Appreciation Rights. |
| 2027-12-31 | End of performance period for Performance Shares. |
| 2028-11-07 | Expiration date for Restricted Stock Units. |
| 2035-11-07 | Expiration date for Stock Appreciation Rights. |
Recommendation
holdThis Form 4 filing details a routine grant of equity compensation to a key executive, Andrea Jean Barry. While the grants of Restricted Stock Units, Stock Appreciation Rights, and performance-based shares align management incentives with shareholder interests, this type of disclosure is standard and does not provide new information that would fundamentally alter the investment thesis for Stepan Company. It confirms ongoing executive retention and compensation strategies but does not present a catalyst for a 'buy' or 'sell' recommendation based solely on this filing.
Keywords
Stepan Company, SCL, Andrea Jean Barry, Form 4, Insider Transaction, Restricted Stock Units, Stock Appreciation Rights, Performance Shares, Equity Compensation, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.